January 9, 2023 — When we were little, our parents told us to take our vitamins so we could grow big and strong. Now ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent (DC ...
December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...
December 16, 2022 — Yvette Honda-Schumacher was 20 weeks pregnant and had just had a routine anatomy ultrasound when ...
December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...
October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it ...

Here is a recap of what DAIC viewers found most interesting during the month of September:
1. Unloading with Impella ...
September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...
September 28, 2022 — Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before ...
September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...
August 23, 2022 — The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial ...